Clinical trials
Esophageal and Gastric Varices clinical trials
Below are recruiting esophageal and gastric varices clinical trials, each written for real people, not researchers. We’re tracking 17 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07532915Recruiting
Two endoscopy methods to prevent stomach vein bleeding
This trial compares two endoscopic (camera-guided) procedures to prevent or treat bleeding from enlarged veins in the stomach. Both approaches aim to stop dangerous bleeding or prevent it from happening in high-risk patients.
Guangzhou, GuangdongAges 18–80 - NCT07253090Recruiting
Blood pressure and vein changes after varices treatment
This trial looks at how endoscopic treatment for enlarged veins in the esophagus (from liver disease) affects certain blood pressure readings. If you have cirrhosis and need treatment to prevent bleeding from these veins, you may be able to join.
HangzhouAges 18–80 - NCT06819566RecruitingPhase 2
Preventing bleeding from enlarged veins in the esophagus
This study tests whether tying off high-risk veins in the esophagus before starting a common liver cancer treatment can prevent bleeding. It is for people with liver cancer that has spread but who have never had cancer treatment before.
Seoul, Song-paAges 19–80 - NCT06961526Recruiting
Preventing varices bleeding in liver cancer patients on immunotherapy
This trial tests if preventing esophageal varices (swollen veins in the food pipe) can reduce bleeding risk in people with advanced liver cancer who are receiving a combination of two drugs (atezolizumab and bevacizumab). It may help those with good liver function and no high-risk varices at the start.
Tanta, GharbyeaAges 18 years+ - NCT07151885Recruiting
Using ultrasound and blood tests to predict varices risk in cirrhosis
This trial tests if a special ultrasound technique combined with liver stiffness and platelet count can predict which patients with cirrhosis have high-risk varices in the esophagus or stomach, potentially reducing the need for repeated endoscopy.
Changchun, JilinAges 18 years+ - NCT07358663Recruiting
Portal hypertension esophageal gastric varices treatment study
This study looks at how well treatments work for people with enlarged veins in the esophagus and stomach caused by a condition called portal hypertension. If you have this condition and have had a CT scan and an upper endoscopy (camera down the throat), you may be able to take part to help doctors understand which treatments work best.
ShanghaiAges 18 years+ - NCT07248722Enrolling by invitation
Pantoprazole after preventive variceal treatment
This trial tests whether a heartburn medication (pantoprazole) helps patients with liver cirrhosis who have had a procedure to treat enlarged veins in the esophagus or stomach. It looks at how well the medicine works when given after this procedure to prevent complications.
Shenyang, LiaoningAges 18 years+ - NCT06306755Recruiting
Risk-based screening for esophageal and gastric cancer
This study tests a new way of screening for esophagus and stomach cancer by using a risk-based approach. It aims to see if this works better than standard screening, and is offered to people in certain villages in China.
Beijing, Beijing MunicipalityAges 50–69 - NCT06736314Recruiting
Removable clip treatment for stomach varices bleeding
This trial tests a removable titanium clip to stop bleeding from enlarged veins in the stomach caused by cirrhosis. It may be an option for patients who are stable enough for this procedure.
Nanjing, JiangsuAges 18–75 - NCT07521332RecruitingPhase 4
Testing Apixaban to Prevent Bleeding Complications in Cirrhosis
This study tests whether a blood thinner called apixaban can safely prevent dangerous bleeding in people with cirrhosis (liver scarring) who have portal hypertension (high blood pressure in veins leading to the liver). The goal is to see if it reduces bleeding risk without causing excessive bleeding.
Hyderābād, SindhAges 18 years+ - NCT06863519Enrolling by invitation
Testing HVPG to guide variceal bleeding prevention
This study tests whether using a special blood pressure measurement in the liver (called HVPG) can help doctors choose the best endoscopic treatment for people with cirrhosis who have had variceal bleeding. If you've had bleeding from varices, this study aims to make your follow-up care more personalized and effective.
Hangzhou, ZhejiangAges 18–80 - NCT06846346RecruitingPhase 2
Testing Ivonescimab with Chemo for Advanced Stomach Cancer
This trial tests a new immunotherapy drug called ivonescimab given together with standard chemotherapy for advanced stomach cancer. It may help your immune system fight the cancer more effectively.
LyonAges 18 years+ - NCT01212250Recruiting
Carvedilol to prevent esophagus bleeding in cirrhosis
This trial tests whether carvedilol can prevent the first development of swollen veins (varices) in the esophagus in people with cirrhosis who do not have them yet. It may help lower the risk of future bleeding from those veins.
New Delhi, National Capital Territory of DelhiAges 18–75 - NCT06970509Recruiting
Improving treatment for stomach bleeding from liver disease
This trial studies better ways to use endoscopy and other treatments to stop bleeding in the stomach or esophagus caused by high blood pressure in the liver (portal hypertension). It may help if you have been diagnosed with portal hypertension and have varices (enlarged veins) in your esophagus or stomach.
Guangzhou, GuangdongAges 18 years+ - NCT03539822RecruitingPhase 1/Phase 2
Cabozantinib and immunotherapy for advanced stomach or bowel cancers
This early-phase study tests a combination of anti-cancer pills and immune-based treatment for people with advanced stomach, esophagus, colorectal, or liver cancer. It aims to shrink tumors and see how safe the treatment is, including whether biopsy testing can help guide future care.
Westwood, KansasAges 18 years+ - NCT06431100Recruiting
A study of TRT therapy for advanced solid tumors
This trial tests a new cell therapy called TRTs for people with advanced cancers like stomach, esophagus, cervical, breast, or lung cancer that no longer respond to standard treatments. The therapy uses your own tumor tissue or fluid to create a personalized treatment.
Zhengzhou, HenanAges 18–75 - NCT05187338RecruitingPhase 1/Phase 2
Study drugs that target immune checkpoints for solid tumors
This early-phase study tests a combination of three immune “checkpoint” medicines in people with advanced solid cancers. It aims to see how well they work and what side effects occur, including when given through a specific liver-focused treatment in eligible patients.
Guangzhou, GuangdongAges 18–70
Hear when a new Esophageal and Gastric Varices trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for esophageal and gastric varices?
- Yes. Clin2 currently lists 17 recruiting esophageal and gastric varices studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a esophageal and gastric varices trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a esophageal and gastric varices trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.